GlobeNewswire
ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
📈
AI Sentiment
Highly Positive
8/10
- Home
- DGX
as of 01-23-2026 3:40pm EST
$181.38
$0.78
-0.43%
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | SECAUCUS |
| Market Cap: | 20.5B | IPO Year: | 1996 |
| Target Price: | $196.69 | AVG Volume (30 days): | 936.9K |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 8.51 | EPS Growth: | 14.49 |
| 52 Week Low/High: | $150.14 - $197.55 | Next Earning Date: | 02-10-2026 |
| Revenue: | $10,850,000,000 | Revenue Growth: | 13.74% |
| Revenue Growth (this year): | 12.37% | Revenue Growth (next year): | 3.54% |
AI-Powered DGX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 0.00%
0.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Quest Diagnostics Incorporated (DGX)
DELANEY MARK E
Sell
SVP & Chief Commercial Officer
DGX Nov 18, 2025
Avg Cost/Share
$187.35
Shares
7,946
Total Value
$1,488,683.10
Owned After
7,530
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| DELANEY MARK E | DGX | SVP & Chief Commercial Officer | Nov 18, 2025 | Sell | $187.35 | 7,946 | $1,488,683.10 | 7,530 |
Latest Quest Diagnostics Incorporated News
DGX Breaking Stock News: Dive into DGX Ticker-Specific Updates for Smart Investing
PR Newswire
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year
📈
AI Sentiment
Highly Positive
9/10
Compare DGX vs Leading Stocks
See how DGX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "DGX Quest Diagnostics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.